Sales Nexus CRM

Heart Association Cautions Against Broad Use of Coronary Artery Calcium Testing

By Advos•
The American Heart Association warns that coronary artery calcium (CAC) testing should be used selectively as a decision aid for people at borderline or intermediate risk of heart attack or stroke, not as a universal screening tool.
Heart Association Cautions Against Broad Use of Coronary Artery Calcium Testing

The American Heart Association is urging caution against widespread use of coronary artery calcium (CAC) testing, emphasizing that the noninvasive CT scan is most valuable when it helps resolve uncertainty about whether to start or intensify cholesterol-lowering treatment. The guidance comes as recent research and media coverage have highlighted the test's potential, prompting the Association to clarify who may benefit and who may not.

A CAC test is a quick, noninvasive scan that detects calcium deposits in the coronary arteries, which can be an early sign of plaque buildup, or atherosclerosis. The resulting calcium score provides additional information about future cardiovascular risk, including heart attack or stroke. The scan takes about 10 to 15 minutes, does not require injected contrast dye and uses a low dose of radiation.

However, the Association stresses that CAC testing is not necessary for everyone. The American Heart Association/American College of Cardiology dyslipidemia guideline supports selective use of CAC scoring, particularly when a person's cardiovascular risk falls in a middle range and there is uncertainty about whether to begin or intensify cholesterol-lowering treatment. The 2026 guideline encourages the use of the American Heart Association’s PREVENT™ equations as the starting point for estimating cardiovascular risk and identifies CAC as a tool to refine treatment decisions when the answer remains unclear.

“The American Heart Association does not recommend broad based use of the CAC test for screening. The Association recommends it as a decision aid for people at borderline or intermediate risk for atherosclerotic cardiovascular disease or heart and blood-vessel disease caused by the buildup of cholesterol-containing plaque in the arteries – but only when the decision about whether to use drug therapy to lower risk is uncertain. It is a tiebreaker test,” said Manesh R. Patel, M.D., FAHA, volunteer president of the American Heart Association and chief of the division of cardiology at Duke University School of Medicine.

Recent studies have found that modern risk estimation with the PREVENT equations can effectively identify coronary artery disease risk for many people, while adding CAC information is particularly useful for those in borderline (3% to less than 5%) and intermediate (5% to less than 10%) risk groups. The Association's guidelines recommend using calcium findings to help inform decisions on the use of statins for men age 40 and older and women age 45 and older with borderline or intermediate 10-year risk of heart attack or stroke.

For consumers, the Association advises that the first step is a conversation with a healthcare professional, not necessarily a scan. People should discuss their overall cardiovascular risk and whether knowing their CAC score would actually change what they do next. The test generally isn't useful when risk is already very low or when appropriate treatment is already clear, such as for those with diabetes or very high cholesterol. It also is not helpful for someone who has already had a heart attack or cardiac catheterization.

The scan, which is typically not covered by health insurance and can cost $100 to $400, detects and measures calcium associated with plaque buildup. A higher score indicates greater potential for plaque burden and future risk. The Association recommends that the “first prescription” for prevention should be lifestyle modification, including avoiding smoking and emphasizing a healthy diet, exercise and sleep as defined by Life’s Essential 8™.

A score of zero is reassuring but not a lifetime “all clear.” It does not rule out noncalcified plaque, and other factors such as diabetes, smoking, very high cholesterol and a strong family history of premature heart disease still matter.

Individuals can learn more about coronary artery calcium testing (CAC test) from the American Heart Association and use the Life's Essential 8™ My Life Check Calculator to assess their own heart health score at home. The Association also offers a national initiative, Catalyzing CAC Testing to Transform Heart Health, and additional resources including the About the PREVENT™ Equations page and the 2026 ACC/American Heart Association cholesterol guideline news release. For more information, visit heart.org or stroke.org.

Advos

Advos

@advos